European authorization for GSK's quadrivalent meningococcal vaccine Nimenrix

被引：0
|
作者：
Riedmann, Eva M.
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2012年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：697 / 697
页数：1
相关论文
共 50 条
  • [21] Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States
    Mbaeyi, Sarah
    Pondo, Tracy
    Blain, Amy
    Yankey, David
    Potts, Caelin
    Cohn, Amanda
    Hariri, Susan
    Shang, Nong
    MacNeil, Jessica R.
    JAMA PEDIATRICS, 2020, 174 (09) : 843 - 851
  • [22] GSK's inactivated quadrivalent seasonal influenza vaccine: no serious AEs in 2019/2020 season
    Reactions Weekly, 2021, 1880 (1) : 9 - 9
  • [23] Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine
    Elias, Johannes
    Findlow, Jamie
    Borrow, Ray
    Tremmel, Angelika
    Frosch, Matthias
    Vogel, Ulrich
    JOURNAL OF OCCUPATIONAL MEDICINE AND TOXICOLOGY, 2013, 8
  • [24] A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age
    Koski, Susanna
    Martinon-Torres, Federico
    Raemet, Mika
    Zolotas, Lefteris
    Newton, Ryan
    Maansson, Roger
    Cutler, Mark
    Peyrani, Paula
    Findlow, Jamie
    Balmer, Paul
    Jodar, Luis
    Gruber, William C.
    Anderson, Annaliesa S.
    Beeslaar, Johannes
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (02) : 463 - 481
  • [25] Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants
    Perrett, Kirsten P.
    Snape, Matthew D.
    Ford, Karen J.
    John, Tessa M.
    Yu, Ly-Mee M.
    Langley, Joanne M.
    McNeil, Shelly
    Dull, Peter M.
    Ceddia, Francesca
    Anemona, Alessandra
    Halperin, Scott A.
    Dobson, Simon
    Pollard, Andrew J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (03) : 186 - 193
  • [26] Antibody Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents
    Baxter, Roger
    Reisinger, Keith
    Block, Stanley L.
    Izu, Allen
    Odrljin, Tatjana
    Dull, Peter
    JOURNAL OF PEDIATRICS, 2014, 164 (06): : 1409 - +
  • [27] Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine
    Johannes Elias
    Jamie Findlow
    Ray Borrow
    Angelika Tremmel
    Matthias Frosch
    Ulrich Vogel
    Journal of Occupational Medicine and Toxicology, 8
  • [28] Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naive toddlers: A randomised, controlled trial
    Knuf, Markus
    Ramet, Mika
    Staerke, Nina Breinholt
    Bertrand-Gerentes, Isabelle
    Thollot, Yael
    B'Chir, Siham
    Arroum, Habiba
    Oster, Philipp
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [29] Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naive and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
    van der Vliet, D.
    Vesikari, T.
    Sandner, B.
    Martinon-Torres, F.
    Muzsay, G.
    Forsten, A.
    Adelt, T.
    Diaz Gonzalez, C.
    Simko, R.
    B'Chir, S.
    Neveu, D.
    Jordanov, E.
    Dhingra, M. S.
    EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [30] Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine
    Khalil, Mohamed
    Al-Mazrou, Yagob
    Findlow, Helen
    Chadha, Helen
    Castells, Valerie Bosch
    Johnson, David R.
    Borrow, Ray
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (10) : 1561 - 1566
12345